Skip to search.
 FTSE 100 Up 3.56%

Abaxis, Inc. (ABAX)

-NasdaqGS
46.87 Down 0.09(0.20%) 20:25 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:46.96
Open:47.19
Bid:47.04 x 100
Ask:47.22 x 100
1y Target Est:63.57
Beta:-0.307399
Earnings Date:19 Oct - 23 Oct (Est.)
Day's Range:46.60 - 47.55
52wk Range:44.07 - 66.89
Volume:123,391
Avg Vol (3m):179,255
Market Cap:1.06b
P/E (ttm):36.27
EPS (ttm):1.29
Div & Yield:0.44 (0.88%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ABAX at this time.

Comparison

Symbol% ChgMkt Cap
ABAXDown 0.20%1.06b
IDXXUp 0.85%6.79b
HSKADown 2.20%218.20m
ALRUp 2.55%4.51b

Key Statistics

Forward P/E (1 yr):30.55
P/S (ttm):5.04
Ex-Dividend Date:01-Sep-15

Analysts

Annual EPS Est (Mar-16) :1.26
Quarterly EPS Est (Sep-15) :0.31
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):1.88

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide blood constituent measurements for clinicians worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback